Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Sai Lata De"'
Autor:
Justin Nicholas, Surendra Kumar Kolli, Pradeep Annamalai Subramani, Sai Lata De, Madison M. Ogbondah, Samantha J. Barnes, Francis Babila Ntumngia, John H. Adams
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-10 (2023)
Abstract Background Acquired functional inhibitory antibodies are one of several humoral immune mechanisms used to neutralize foreign pathogens. In vitro bioassays are useful tools for quantifying antibody-mediated inhibition and evaluating anti-para
Externí odkaz:
https://doaj.org/article/ef907aea9d314903925099b669db0dc3
Autor:
Pongsakorn Thawornpan, Chayapat Malee, Piyawan Kochayoo, Kittikorn Wangriatisak, Chaniya Leepiyasakulchai, Francis B. Ntumngia, Sai Lata De, John H. Adams, Patchanee Chootong
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract Plasmodium vivax Duffy Binding Protein region II (PvDBPII) is a leading vaccine candidate against blood-stage vivax malaria. Anti-PvDBPII antibodies potentially block parasite invasion by inhibition of erythrocyte binding. However, knowledge
Externí odkaz:
https://doaj.org/article/5fb7b50a80ce45fbb6b781a5de8698fd
Autor:
Justin Nicholas, Sai Lata De, Pongsakorn Thawornpan, Awtum M Brashear, Surendra Kumar Kolli, Pradeep Annamalai Subramani, Samantha J Barnes, Liwang Cui, Patchanee Chootong, Francis Babila Ntumngia, John H Adams
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 9, p e0011598 (2023)
Plasmodium vivax pre-erythrocytic (PE) vaccine research has lagged far behind efforts to develop Plasmodium falciparum vaccines. There is a critical gap in our knowledge of PE antigen targets that can induce functionally inhibitory neutralizing antib
Externí odkaz:
https://doaj.org/article/08bbc6fea1f74b929c247c9d79da502b
Publikováno v:
Heliyon, Vol 9, Iss 4, Pp e14729- (2023)
Underserved, low-income, rural and certain migrant populations have greater risks and higher incidences of Coronavirus disease 2019 (COVID-19) than more privileged populations. Current in-person testing methods have limitations, namely exposure risk,
Externí odkaz:
https://doaj.org/article/3bcd20ee5ef443978d49e8953ad04289
Autor:
Pongsakorn Thawornpan, Siriruk Changrob, Piyawan Kochayoo, Kittikorn Wangriatisak, Francis B. Ntumngia, Sai Lata De, Eun-Taek Han, John H. Adams, Patchanee Chootong
Publikováno v:
PLoS ONE, Vol 17, Iss 10 (2022)
Duffy binding protein region II (DBPII) is considered a strong potential vaccine candidate of blood-stage P. vivax. However, the highly polymorphic nature of this protein often misdirects immune responses, leading them to be strain-specific. Details
Externí odkaz:
https://doaj.org/article/54c352cc92ca4929b6cf6c0c20da53b2
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 14, Iss 4, p e0008182 (2020)
BackgroundStudies of the human filarial parasite have been hampered by the fact that they are obligate parasites with long life cycles. In other pathogenic infections, in vivo imaging systems (IVIS) have proven extremely useful in studying pathogenes
Externí odkaz:
https://doaj.org/article/48c01eb71c934bd5b11e20a739897b88
Autor:
Danielle I. Stanisic, James Fink, Johanna Mayer, Sarah Coghill, Letitia Gore, Xue Q. Liu, Ibrahim El-Deeb, Ingrid B. Rodriguez, Jessica Powell, Nicole M. Willemsen, Sai Lata De, Mei-Fong Ho, Stephen L. Hoffman, John Gerrard, Michael F. Good
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-16 (2018)
Abstract Background The continuing morbidity and mortality associated with infection with malaria parasites highlights the urgent need for a vaccine. The efficacy of sub-unit vaccines tested in clinical trials in malaria-endemic areas has thus far be
Externí odkaz:
https://doaj.org/article/d9515cdddde74b63912c381b0c0e1f2f
Autor:
Pongsakorn Thawornpan, Chayapat Malee, Piyawan Kochayoo, Kittikorn Wangriatisak, Chaniya Leepiyasakulchai, Francis B. Ntumngia, Sai Lata De, John H. Adams, Patchanee Chootong
Publikováno v:
Scientific Reports. 13
Plasmodium vivax Duffy Binding Protein region II (PvDBPII) is a leading vaccine candidate against blood-stage vivax malaria. Anti-PvDBPII antibodies potentially block parasite invasion by inhibition of erythrocyte binding. However, knowledge of PvDBP
Publikováno v:
Expert Rev Vaccines
INTRODUCTION: Plasmodium vivax causes significant public health problems in endemic regions. A vaccine to prevent disease is critical, considering the rapid spread of drug-resistant parasite strains, and the development of hypnozoites in the liver wi
Publikováno v:
SSRN Electronic Journal.